Article
Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo
16 Nov 2017
Abstract excerpt
PyVs can cause significant morbidity and mortality in immunocompromised individuals. No clinically efficacious anti-PyV therapeutic agents are available. A recently identified inhibitor of retrograde transport, Retro-2 cycl , blocks movement of PyV virion-containing vesicles from early endosomes to the endoplasmic reticulum, an early step in the PyV life cycle. Retro-2 cycl and its derivatives have been shown to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
